Mazdutide
Reviewed by Fat Man in the Arena · Updated March 2026
Key Takeaway
Mazdutide is a dual GLP-1/glucagon receptor agonist developed by Innovent Biologics, primarily studied in Chinese populations.
How it works
Dual GLP-1 and glucagon receptor agonism for appetite suppression and increased energy expenditure.
Benefits
- Significant weight loss in Phase 3 trials
- Improved metabolic markers
Side effects
- Nausea
- Diarrhea
- GI side effects similar to other GLP-1 agonists
Dosing protocol
Typical Dose
3 mg to 9 mg weekly
Frequency
Once weekly
Approved in China. Not yet available in the US.
Related peptides
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.